Cargando…
Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design
OBJECTIVES: To measure the adherence to polytherapy after myocardial infarction (MI), to compare the proportions of variation attributable to hospitals of discharge and to primary care providers, and to identify determinants of adherence to medications. SETTING: This is a population-based study. Dat...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823440/ https://www.ncbi.nlm.nih.gov/pubmed/27044584 http://dx.doi.org/10.1136/bmjopen-2015-010926 |
_version_ | 1782425917084139520 |
---|---|
author | Di Martino, Mirko Alagna, Michela Cappai, Giovanna Mataloni, Francesca Lallo, Adele Perucci, Carlo Alberto Davoli, Marina Fusco, Danilo |
author_facet | Di Martino, Mirko Alagna, Michela Cappai, Giovanna Mataloni, Francesca Lallo, Adele Perucci, Carlo Alberto Davoli, Marina Fusco, Danilo |
author_sort | Di Martino, Mirko |
collection | PubMed |
description | OBJECTIVES: To measure the adherence to polytherapy after myocardial infarction (MI), to compare the proportions of variation attributable to hospitals of discharge and to primary care providers, and to identify determinants of adherence to medications. SETTING: This is a population-based study. Data were obtained from the Information Systems of the Lazio Region, Italy (5 million inhabitants). PARTICIPANTS: Patients hospitalised with incident MI in 2007–2010. OUTCOME MEASURE: The outcome was chronic polytherapy after MI. Adherence was defined as a medication possession ratio ≥0.75 for at least three of the following drugs: antiplatelets, β-blockers, ACEI angiotensin receptor blockers, statins. DESIGN AND ANALYSIS: A 2-year cohort study was performed. Cross-classified multilevel models were applied to analyse geographic variation and compare proportions of variability attributable to hospitals of discharge and primary care providers. The variance components were expressed as median ORs MORs. If the MOR is 1.00, there is no variation between clusters. If there is considerable between-cluster variation, the MOR will be large. RESULTS: A total of 9606 patients were enrolled. About 63% were adherent to chronic polytherapy. Adherence was higher for patients discharged from cardiology wards (OR=1.56 vs other wards, p<0.001) and for patients with general practitioners working in group practice (OR=1.14 vs single-handed, p=0.042). A relevant variation in adherence was detected between local health districts (MOR=1.24, p<0.001). When introducing the hospital of discharge as a cross-classified level, the variation between local health districts decreased (MOR=1.13, p=0.020) and the variability attributable to hospitals of discharge was significantly higher (MOR=1.37, p<0.001). CONCLUSIONS: Secondary prevention pharmacotherapy after MI is not consistent with clinical guidelines. The relevant geographic variation raises equity issues in access to optimal care. Adherence was influenced more by the hospital that discharged the patient than by the primary care providers. Cross-classified models proved to be a useful tool for defining priority areas for more targeted interventions. |
format | Online Article Text |
id | pubmed-4823440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48234402016-04-19 Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design Di Martino, Mirko Alagna, Michela Cappai, Giovanna Mataloni, Francesca Lallo, Adele Perucci, Carlo Alberto Davoli, Marina Fusco, Danilo BMJ Open Health Policy OBJECTIVES: To measure the adherence to polytherapy after myocardial infarction (MI), to compare the proportions of variation attributable to hospitals of discharge and to primary care providers, and to identify determinants of adherence to medications. SETTING: This is a population-based study. Data were obtained from the Information Systems of the Lazio Region, Italy (5 million inhabitants). PARTICIPANTS: Patients hospitalised with incident MI in 2007–2010. OUTCOME MEASURE: The outcome was chronic polytherapy after MI. Adherence was defined as a medication possession ratio ≥0.75 for at least three of the following drugs: antiplatelets, β-blockers, ACEI angiotensin receptor blockers, statins. DESIGN AND ANALYSIS: A 2-year cohort study was performed. Cross-classified multilevel models were applied to analyse geographic variation and compare proportions of variability attributable to hospitals of discharge and primary care providers. The variance components were expressed as median ORs MORs. If the MOR is 1.00, there is no variation between clusters. If there is considerable between-cluster variation, the MOR will be large. RESULTS: A total of 9606 patients were enrolled. About 63% were adherent to chronic polytherapy. Adherence was higher for patients discharged from cardiology wards (OR=1.56 vs other wards, p<0.001) and for patients with general practitioners working in group practice (OR=1.14 vs single-handed, p=0.042). A relevant variation in adherence was detected between local health districts (MOR=1.24, p<0.001). When introducing the hospital of discharge as a cross-classified level, the variation between local health districts decreased (MOR=1.13, p=0.020) and the variability attributable to hospitals of discharge was significantly higher (MOR=1.37, p<0.001). CONCLUSIONS: Secondary prevention pharmacotherapy after MI is not consistent with clinical guidelines. The relevant geographic variation raises equity issues in access to optimal care. Adherence was influenced more by the hospital that discharged the patient than by the primary care providers. Cross-classified models proved to be a useful tool for defining priority areas for more targeted interventions. BMJ Publishing Group 2016-04-04 /pmc/articles/PMC4823440/ /pubmed/27044584 http://dx.doi.org/10.1136/bmjopen-2015-010926 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Health Policy Di Martino, Mirko Alagna, Michela Cappai, Giovanna Mataloni, Francesca Lallo, Adele Perucci, Carlo Alberto Davoli, Marina Fusco, Danilo Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design |
title | Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design |
title_full | Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design |
title_fullStr | Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design |
title_full_unstemmed | Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design |
title_short | Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design |
title_sort | adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? a cross-classified multilevel design |
topic | Health Policy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823440/ https://www.ncbi.nlm.nih.gov/pubmed/27044584 http://dx.doi.org/10.1136/bmjopen-2015-010926 |
work_keys_str_mv | AT dimartinomirko adherencetoevidencebaseddrugtherapiesaftermyocardialinfarctionisgeographicvariationrelatedtohospitalofdischargeorprimarycareprovidersacrossclassifiedmultileveldesign AT alagnamichela adherencetoevidencebaseddrugtherapiesaftermyocardialinfarctionisgeographicvariationrelatedtohospitalofdischargeorprimarycareprovidersacrossclassifiedmultileveldesign AT cappaigiovanna adherencetoevidencebaseddrugtherapiesaftermyocardialinfarctionisgeographicvariationrelatedtohospitalofdischargeorprimarycareprovidersacrossclassifiedmultileveldesign AT matalonifrancesca adherencetoevidencebaseddrugtherapiesaftermyocardialinfarctionisgeographicvariationrelatedtohospitalofdischargeorprimarycareprovidersacrossclassifiedmultileveldesign AT lalloadele adherencetoevidencebaseddrugtherapiesaftermyocardialinfarctionisgeographicvariationrelatedtohospitalofdischargeorprimarycareprovidersacrossclassifiedmultileveldesign AT peruccicarloalberto adherencetoevidencebaseddrugtherapiesaftermyocardialinfarctionisgeographicvariationrelatedtohospitalofdischargeorprimarycareprovidersacrossclassifiedmultileveldesign AT davolimarina adherencetoevidencebaseddrugtherapiesaftermyocardialinfarctionisgeographicvariationrelatedtohospitalofdischargeorprimarycareprovidersacrossclassifiedmultileveldesign AT fuscodanilo adherencetoevidencebaseddrugtherapiesaftermyocardialinfarctionisgeographicvariationrelatedtohospitalofdischargeorprimarycareprovidersacrossclassifiedmultileveldesign |